Acrivastine 8 mg Suppliers & Bulk Manufacturers
Available Forms: Capsules
Available Strengths: 8 mg
Reference Brands: Semprex (USA)
Category: Respiratory Disorder
Acrivastine is a second-generation antihistamine (H₁-receptor antagonist) used to relieve symptoms of allergic conditions, such as hay fever (seasonal allergic rhinitis), perennial allergic rhinitis, and urticaria (hives). It works by blocking histamine H₁ receptors, preventing the action of histamine, which is responsible for allergy symptoms like sneezing, itching, runny nose, and watery eyes.
Manufacture or export Acrivastine? List it or send an offer →
Product Description:
Acrivastine is a second-generation antihistamine derived from triprolidine, and it occupies an unusual position within its class. Most second-generation agents were developed for once-daily dosing; acrivastine has a short half-life of around two hours and is dosed three times daily. That is a commercial disadvantage against cetirizine or loratadine, but it gives a faster onset, which suits intermittent symptomatic use rather than continuous seasonal control.
It is supplied as 8 mg capsules, and in several markets in fixed combination with pseudoephedrine for concurrent congestion. Excretion is largely renal and unchanged, so dose adjustment is specified in renal impairment.
Sourcing notes. Acrivastine has a narrow geographic footprint compared with the major second-generation antihistamines, with its strongest presence in the United Kingdom and United States. That limits the number of manufacturers holding current dossiers and makes it slower to register in markets without precedent. Where the combination product with pseudoephedrine is the requirement, note that the pseudoephedrine component brings precursor-control obligations in most jurisdictions — import and export authorisations may be required for the finished product, not only for the raw material. Where a buyer needs a non-sedating antihistamine rather than acrivastine specifically, the widely genericised alternatives will be quicker and cheaper to supply.
Acrivastine — third party manufacturing & bulk supply
Acrivastine 8 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Acrivastine is supplied as Capsules — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Acrivastine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Acrivastine →Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.
Frequently Asked Questions
Related Products
Varenicline
Strength:
0.5 mg, 1 mg
Form: Tablets
Reference Brands: Chantix (USA), Champix(EU/UK)
View DetailsLevodropropizine
Strength:
60mg , 30mg/5ml
Form: Tablets / Syrups
Reference Brands: Levopront
View DetailsErdosteine
Strength:
300mg, 175 mg/5 mL
Form: Tablets / Capsules / oral suspension
Reference Brands: Erdotin (EU)
View DetailsOxomemazine
Strength:
0.33 mg/mL, 1.65 mg, 2.5 mg
Form: Syrup/ Tablet
Reference Brands: -
View DetailsTiotropium Bromide
Strength:
18 mcg per capsule
Form: Dry Powder for Inhalation (DPI)
Reference Brands: Spiriva® HandiHaler®(US & EU)
View DetailsTiotropium Bromide
Strength:
1.25 mcg/ actuation & 2.5 mcg/actuation
Form: Soft Mist Inhaler
Reference Brands: Spiriva® Respimat®(Eu & US)
View DetailsFormoterol Fumarate /Budesonide
Strength:
DPI: 100 mcg Budesonide / 6 mcg Formoterol, ; MDI: 80 mcg Budesonide / 4.5 mcg Formoterol Fumarate, 160 mcg Budesonide / 4.5 mcg Formoterol Fumarate
Form: Powder For Inhalation(DPI/MDI)
Reference Brands: Symbicort®(US); Symbicort® Turbohaler® (EU - various strengths available)
View DetailsLevosalbutamol
Strength:
0.31 mg/3 mL, 0.63 mg/3 mL, and 1.25 mg/3 mL.
Form: Inhalation Solution
Reference Brands: Xopenex®(US)
View DetailsUsually answered within 48 hours | GMP documents shared before you commit